India and the Patent Wars

Pharmaceuticals in the New Intellectual Property Regime
ILR Press
  • 1. Auflage
  • |
  • erschienen am 15. November 2017
  • |
  • 202 Seiten
978-1-5017-1397-2 (ISBN)
India and the Patent Wars contributes to an international debate over the costs of medicine and restrictions on access under stringent patent laws showing how activists and drug companies in low-income countries seize agency and exert influence over these processes. Murphy Halliburton contributes to analyses of globalization within the fields of anthropology, sociology, law, and public health by drawing on interviews and ethnographic work with pharmaceutical producers in India and the United States. India has been at the center of emerging controversies around patent rights related to pharmaceutical production and local medical knowledge. Halliburton shows that Big Pharma is not all-powerful, and that local activists and practitioners of ayurveda, India's largest indigenous medical system, have been able to undermine the aspirations of multinational companies and the WTO. Halliburton traces how key drug prices have gone down, not up, in low-income countries under the new patent regime through partnerships between US- and India-based companies, but warns us to be aware of access to essential medicines in low- and middle-income countries going forward.
  • Englisch
  • Ithaca
  • |
  • USA
Cornell University Press
  • Für Beruf und Forschung
  • |
  • Interest Age: From 18 years
  • Digitale Ausgabe
  • 4 b&w halftones, 4 s/w Photographien bzw. Rasterbilder
  • |
  • 4 b&w halftones
  • Höhe: 229 mm
  • |
  • Breite: 152 mm
978-1-5017-1397-2 (9781501713972)
weitere Ausgaben werden ermittelt
Murphy Halliburton
  • Cover
  • Contents
  • Acknowledgments
  • Note on Names of Medications
  • Introduction
  • 1. The Invention and Expansion of Intellectual Property
  • 2. The New Patent Regime: The Activists and Their Allies
  • 3. Ayurvedic Dilemmas: Innovation, Ownership, and Resistance
  • 4. The Gilead Model and the Perspective of Big Pharma
  • 5. The View from Hyderabad: The "Indian" Pharmaceutical Industry and the New Patent Regime
  • Conclusion
  • Notes
  • References
  • Index
"In India and the Patent Wars, Murphy Halliburton addresses the question of how IP law and trade agreements should deal with sophisticated knowledge systems organized by principles quite unlike those of the West. Halliburton convincingly challenges the conventional view that pits Big Pharma and allopathic medicine against local knowledge-keepers and holistic healing."

--Michael F. Brown, author of Who Owns Native Culture?

Download (sofort verfügbar)